The National Heart, Lung, and Blood Institute (NHLBI) is accepting SBIR/STTR applications that focus on developing innovative biomaterials-based technologies with high commercialization potential. Applicants should be working on cutting-edge biomaterials, including AI-mediated design, tissue organoids, nanotechnology integration, and novel biomedical products relevant to heart, lung, blood, and sleep (HLBS) diseases.

Visit the SBIR notice webpage for more detailed application deadlines and guidelines.